Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2023 Earnings Conference Call May 30, 2023 8:00 AM ET

Company Participants

Yusheng Han - Founder, Chairman & CEO

Leo Li - CFO

Joe Zhang - CTO

Conference Call Participants

Alexis Yan - Morgan Stanley

Operator

Good day, and thank you, for standing by. Welcome to the Burning Rock’s 2023 Q1 Earnings Conference Call.

Before we begin, I’d like to remind you that this conference call contains forward-looking statements within the meaning of Section 21(e) of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will, expects, anticipates, future, intends, plans, believes, estimates, targets, confidence, and similar statements.

Statements that are not historical facts, including statements about Burning Rock’s beliefs and expectations, are forward-looking statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rock’s control.

Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in any such statements. Burning Rock does not undertake any obligation [Technical Difficulty] forward-looking statements as a result of new information, future events or otherwise, except as required under applicable law.

At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference call is being recorded.

With that, I would now like to turn the call over to your first speaker today, Mr. Han, CEO of the company. Thank you. Please go ahead.

Yusheng Han

Thank you. Welcome to Burning Rock’s 2023 Q1 conference call. I’m Yusheng Han, the CEO and Founder of Burning Rock. So today, we also have our CTO, Joe Zhang; and CFO, Leo Li online. So before the presentation, I would say that, this quarter's data, although not a lot of new information, but very important information and making us exciting.

So let's turn to Page 3. In case, there are some investors who are not very familiar with Burning Rock, I hereby illustrates, what we do. So our business started from tissue based therapy selection and then expanded to multi-directions of a liquid biopsy, including liquid-based therapy selection, MRD, and multi-cancer early detection. We have three business units providing products, and services to doctors, pharmas and consumers.